Simmons Reports Record 2018 Results
PINE BLUFF, Ark., Jan. 22, 2019 (GLOBE NEWSWIRE) — Simmons First National Corporation (NASDAQ: SFNC) today announced record net income […]
United Community Banks, Inc. Announces Fourth Quarter Results
Return on Assets of 1.43% and Return on Common Equity of 12.08% GREENVILLE, S.C., Jan. 22, 2019 (GLOBE NEWSWIRE) — […]
First Financial Northwest, Inc. Announces Federal Government Shutdown Assistance
RENTON, Wash., Jan. 22, 2019 (GLOBE NEWSWIRE) — First Financial Northwest, Inc. (the “Company”) (NASDAQ GS: FFNW), the holding company for First […]
TSX News -
Bellatrix Announces Voluntary NYSE Delisting
CALGARY, Alberta, Jan. 22, 2019 (GLOBE NEWSWIRE) — Bellatrix Exploration Ltd. (“Bellatrix” or the “Company”) (TSX, NYSE: BXE) announces that […]
PROREIT Announces January 2019 Distribution
MONTREAL, Jan. 22, 2019 (GLOBE NEWSWIRE) — PRO Real Estate Investment Trust (“PROREIT” or the “REIT”) (TSXV: PRV.UN) announced today […]
Mid-Con Energy Partners, LP Announces Quarterly Distribution on Preferred Units
TULSA, Jan. 22, 2019 (GLOBE NEWSWIRE) — Mid-Con Energy Partners, LP (NASDAQ: MCEP) (“Mid-Con Energy” or the “Partnership”) announces that […]
FormFactor to Announce Fourth Quarter 2018 Financial Results on February 6th
LIVERMORE, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) will report financial results for its 2018 fiscal […]
Navient posts fourth-quarter and full-year 2018 financial results
WILMINGTON, Del., Jan. 22, 2019 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leading asset management and business processing services company, […]
Tolima Gold Announces Name Change to Amilot Capital Inc., Share Consolidation and Amendments to its Articles
NOT FOR DISTRIBUTION IN THE UNITED STATES OR FOR DISSEMINATION TO U.S. NEWS WIRE SERVICES TORONTO, Jan. 22, 2019 (GLOBE […]
Bellerophon Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
WARREN, N.J., Jan. 22, 2019 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics […]
